News from cardium therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 03, 2014, 09:00 ET Cardium Announces Strategic Collaboration And Funding With Taxus Pharmaceuticals To Support Commercial Development Of Advanced Regenerative Therapeutics

Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has entered into a strategic collaboration and funding arrangement with Shanxi...


Jan 27, 2014, 09:00 ET Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings

Cardium Therapeutics Inc. (Ticker Symbol: CRXM) reported on the Company's strategic focus on its two advanced regenerative medicine therapeutics,...


Jan 24, 2014, 09:00 ET Cardium Common Stock To Begin Trading On The OTCQB Market

As previously reported, Cardium Therapeutics, an advanced regenerative therapeutics company, today announced that its common stock will begin trading ...


Dec 31, 2013, 09:00 ET Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Cardium Therapeutics (NYSE MKT: CXM) today reported on advancements of the Company's two key biologics products, its Generx® candidate for the...


Dec 20, 2013, 09:00 ET Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing. As previously reported, a communication from the staff of the...


Dec 04, 2013, 09:00 ET Cardium's Excellagen Assigned Q Code For Product Reimbursement

Cardium Therapeutics (NYSE MKT: CXM) today announced that Cardium's Excellagen®, a wound care product indicated for the treatment of hard to heal...


Dec 03, 2013, 09:00 ET LifeAgain's Bluemetric Select Life Insurance Now Offered At Lifequotes.com

LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced that its BlueMetric Select...


Nov 19, 2013, 09:00 ET Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2013, and reported on recent...


Nov 08, 2013, 09:00 ET Cardium Announces Publication On Use Of Excellagen For Managing Chronic Pressure Ulcers In Elderly Patients

Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of a case study, "Serial Sharp Debridement and Formulated Collagen Gel to Treat...


Oct 07, 2013, 10:27 ET Cardium Provides Update On Exchange Listing

Cardium Therapeutics (NYSE MKT: CXM) today provided an update on its exchange listing. As previously reported, a communication from the staff of the...


Sep 27, 2013, 03:54 ET Unusual Trading Activity In Cardium Common Stock

Cardium Therapeutics (NYSE MKT: CXM) today released the following statement. (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) In view...


Aug 14, 2013, 09:00 ET Cardium Reports On Second Quarter 2013 Financial Results And Recent Business Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the second quarter ended June 30, 2013, and reported on recent...


Aug 12, 2013, 09:00 ET Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells

Cardium Therapeutics (NYSE MKT: CXM) today reported on a research collaboration with researchers at Boston Children's Hospital, to assess the medical ...


Aug 07, 2013, 09:00 ET Cardium Announces Excellagen Distribution Agreement With Kasiak For Germany And Switzerland

Cardium Therapeutics (NYSE MKT: CXM) today announced that it has entered into a distribution agreement with Kasiak Holdings AG for the marketing and...


Aug 05, 2013, 09:00 ET Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties

Cardium Therapeutics (NYSE MKT: CXM) today announced that it has filed a new 510(k) submission for its current FDA-cleared Excellagen® advanced wound ...


Jul 19, 2013, 09:00 ET Cardium Completes Preferred Stock Financing

Cardium Therapeutics (NYSE MKT: CXM) today announced the completion of the second tranche of its previously described registered direct offering...


Jul 18, 2013, 09:00 ET Cardium Announces Reverse Stock Split

Cardium Therapeutics (NYSE MKT: CXM) announced a 1-for-20 reverse split of the Company's issued and outstanding common stock effective at the open of ...


Jul 02, 2013, 04:54 ET Cardium Announces Final Voting Results Of Annual Meeting Of Stockholders

Cardium Therapeutics (NYSE MKT: CXM) today reported the voting results of its reconvened annual meeting of stockholders held earlier today. The...


Jun 21, 2013, 12:58 ET Cardium Announces Temporary Adjournment of Annual Meeting To Be Reconvened On July 2, 2013

Cardium Therapeutics (NYSE MKT: CXM) held its reconvened Annual Meeting of Stockholders earlier today and has temporarily adjourned the meeting to...


Jun 06, 2013, 12:43 ET Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013

Cardium Therapeutics (NYSE MKT: CXM) held its Annual Meeting of Stockholders earlier today. The proposals considered at the Annual Meeting are...


May 28, 2013, 09:00 ET Cardium Announces Favorable Recommendations From ISS And Glass Lewis For Annual Meeting Proposals

Cardium Therapeutics (NYSE MKT: CXM) announced today that Institutional Shareholder Services, Inc. ("ISS") and Glass, Lewis & Co., LLC ("Glass...


May 15, 2013, 09:00 ET Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, and reported on highlights and ...


May 02, 2013, 09:00 ET Cardium Announces Generx Publication In Molecular Therapy

Cardium Therapeutics (NYSE MKT: CXM) today announced a publication, "Mechanistic, Technical, and Clinical Perspectives in Therapeutic Stimulation of...


Apr 30, 2013, 09:00 ET Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting

Cardium Therapeutics (NYSE MKT: CXM) today announced that the Company will present a poster demonstrating the clinical benefits of Excellagen® in...


Apr 05, 2013, 08:31 ET Cardium Presents Year-End 2012 Financial Results And Recent Developments

Cardium Therapeutics (NYSE MKT: CXM) today presented highlights of financial results for fiscal year ended December 31, 2012, and other recent...